Neurology

Panelists discuss how emerging therapeutic targets, including amyloid-beta plaques, tau protein aggregation, inflammation modulation, and…

Panelists discuss how recent advances in Alzheimer’s disease, including amyloid-targeting therapies like lecanemab and donanemab,…

Here's some of what is coming soon to NeurologyLive® this week.: Source: Neurology Read More

Presented at the 2025 PNS Annual Meeting, phase 2 ARDA data showed empasiprubart reduced IVIg…

New data from a phase 2 study presented at the 2025 PNS Annual Meeting showed…

Patients with Guillain-Barré syndrome treated with tanruprubart, formerly known as ANX005, reported significant benefits in…

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of…

Post Content: Source: Neurology Read More

A pair of committee chairs for the Peripheral Nerve Society’s Annual Meeting shared key sessions…

Neurology News Network. for the week ending May 10, 2025. : Source: Neurology Read More